Abstract
The therapeutic plasma exchange is an alternative medical tool in certain pathologies in which conventional treatment has not obtained an effective response. In clinical practice therapeutic plasma exchange is also known as therapeutic plasma exchange, in which a given volume of plasma is removed, in order to remove particles of high molecular weight, pathogens or decrease the level of circulating immune complexes or other components present plasma involved in the pathological immune response and are held responsible for a disease or its clinical manifestations. The American Society for Apheresis (ASFA for its acronym in English) and the American Association of Blood Banks (AABB for its acronym in English) conducted a clinical guidelines based on evidence and updated periodically. The latest update was published in 2013. In this article we summarize the evidence published in these guidelines and scientific literature until January 2015 that evaluates the usefulness of plasma / plasma replacement in critically ill patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
